title: Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis.
authors.affiliation: Service de Médecine Interne, CHU Timone, Marseille, France.
authors.forename: J
authors.initials: J
authors.lastname: Serratrice
authors.forename: B
authors.initials: B
authors.lastname: Granel
authors.forename: L
authors.initials: L
authors.lastname: Swiader
authors.forename: P
authors.initials: P
authors.lastname: Disdier
authors.forename: C
authors.initials: C
authors.lastname: De Roux-Serratrice
authors.forename: D
authors.initials: D
authors.lastname: Raccah
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiller
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003622:Dapsone / Q000627:therapeutic use*; D004906:Erythrocyte Count; D005215:Fasting; D006442:Glycated Hemoglobin / Q000187:drug effects / Q000378:metabolism*; D006461:Hemolysis; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D011081:Polychondritis, Relapsing / Q000097:blood / Q000150:complications*
chemical_list: D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001786:Blood Glucose; D003622:Dapsone; D006442:Glycated Hemoglobin